The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia

To minimize the spread of Coronavirus Disease-2019, Saudi Arabia imposed a nationwide lockdown for over 6 weeks. We examined the impact of lockdown on glycemic control in individuals with type 1 diabetes (T1D) using continuous glucose monitoring (CGM); and assessed whether changes in glycemic contro...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes research and clinical practice 2021-03, Vol.173, p.108682-108682, Article 108682
Main Authors: Alharthi, Sahar K., Alyusuf, Ebtihal Y., Alguwaihes, Abdullah M., Alfadda, Assim, Al-Sofiani, Mohammed E.
Format: Article
Language:English
Subjects:
Adolescent
Adult
Blood Glucose - metabolism
Blood Glucose Self-Monitoring - methods
Communicable Disease Control - methods
Communicable Disease Control - statistics & numerical data
Continuous Glucose Monitoring
COVID-19
COVID-19 - epidemiology
Diabetes Mellitus, Type 1 - blood
Diabetes Mellitus, Type 1 - drug therapy
Diabetes Mellitus, Type 1 - epidemiology
Disease Outbreaks
Female
Glycemic Control - methods
Glycemic Control - standards
Humans
Hypoglycemic Agents - therapeutic use
Lockdown
Male
Program Evaluation
Quarantine - methods
Quarantine - statistics & numerical data
Retrospective Studies
SARS-CoV-2
Saudi Arabia - epidemiology
Telemedicine
Telemedicine - organization & administration
Telemedicine - statistics & numerical data
Type 1 Diabetes
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To minimize the spread of Coronavirus Disease-2019, Saudi Arabia imposed a nationwide lockdown for over 6 weeks. We examined the impact of lockdown on glycemic control in individuals with type 1 diabetes (T1D) using continuous glucose monitoring (CGM); and assessed whether changes in glycemic control differ between those who attended a telemedicine visit during lockdown versus those who did not. Flash CGM data from 101 individuals with T1D were retrospectively evaluated. Participants were categorized into two groups: Attended a telemedicine visit during lockdown (n = 61) or did not attend (n = 40). Changes in CGM metrics from the last 2 weeks pre-lockdown period (Feb 25 - March 9, 2020) to the last 2 weeks of complete lockdown period (April 7–20, 2020) were examined in the two groups. Those who attended a telemedicine visit during the lockdown period had a significant improvement in the following CGM metrics by the end of lockdown: Average glucose (from 180 to 159 mg/dl, p 
ISSN:0168-8227
1872-8227
DOI:10.1016/j.diabres.2021.108682